122 related articles for article (PubMed ID: 8822140)
1. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma.
Iversen LH; Thorlacius-Ussing O
Thromb Res; 1996 Jan; 81(2):253-61. PubMed ID: 8822140
[TBL] [Abstract][Full Text] [Related]
2. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
Iversen LH; Okholm M; Thorlacius-Ussing O
Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
[TBL] [Abstract][Full Text] [Related]
3. Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia.
Bounameaux H; Righetti A; de Moerloose P; Bongard O; Reber G
Thromb Res; 1992 Jan; 65(1):27-32. PubMed ID: 1604440
[TBL] [Abstract][Full Text] [Related]
4. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
5. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
6. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
7. Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion.
Suzuki M; Kudo A; Kitakami A; Doi M; Kubo N; Kuroda K; Ogawa A
Acta Neurochir (Wien); 1998; 140(3):261-5; discussion 265-6. PubMed ID: 9638263
[TBL] [Abstract][Full Text] [Related]
8. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
van Wersch JW; van Mourik-Alderliesten CH; Coremans A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
[TBL] [Abstract][Full Text] [Related]
9. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.
Nevard CH; Jurd KM; Lane DA; Philippou H; Haycock GB; Hunt BJ
Thromb Haemost; 1997 Dec; 78(6):1450-5. PubMed ID: 9423793
[TBL] [Abstract][Full Text] [Related]
10. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation parameters in retinal arterial occlusion.
Sagripanti A; Romani A; Ferretti A; Ragone MC; Baicchi U; Carpi A; Nardi M
Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):480-3. PubMed ID: 10379608
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment.
Tomura S; Nakamura Y; Deguchi F; Ando R; Chida Y; Marumo F
Thromb Res; 1991 Oct; 64(1):81-90. PubMed ID: 1776141
[TBL] [Abstract][Full Text] [Related]
13. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
[TBL] [Abstract][Full Text] [Related]
15. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
Leroy-Matheron C; Gouault-Heilmann M
Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
[TBL] [Abstract][Full Text] [Related]
16. Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1 + 2 and thrombin-antithrombin complexes.
Reber G; Amiral J; de Moerloose P
Thromb Res; 1998 Jul; 91(1):45-7. PubMed ID: 9700853
[No Abstract] [Full Text] [Related]
17. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation.
Nakagawa K; Tsuji H; Masuda H; Yamada K; Yamada Y; Yoneda M; Takada O; Tamagaki T; Yamagami M; Uno M
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):725-30. PubMed ID: 7865678
[TBL] [Abstract][Full Text] [Related]
19. Pre-analytical variation in the measurements of sensitive markers of coagulation and fibrinolysis: the influence of venipuncture and mixing of blood.
Iversen LH
Haemostasis; 1997; 27(3):119-24. PubMed ID: 9306128
[TBL] [Abstract][Full Text] [Related]
20. Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy.
Schietroma M; Carlei F; Mownah A; Franchi L; Mazzotta C; Sozio A; Amicucci G
Surg Endosc; 2004 Jul; 18(7):1090-6. PubMed ID: 15136925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
